Stephenson Harwood
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
The ‘knowledgeable’ and ’pragmatic’ team at Stephenson Harwood advises a host of life sciences clients on corporate and commercial transactions, including VC investments, M&A, and collaboration and commercialisation arrangements. The practice is led by ‘top-tier’ Alexandra Pygall, noted for her experience in contentious and non-contentious IP matters, including transactions and litigation. Both recognised for their ’expertise and commitment’ Dan Holland focuses on the manufacturing and distribution of cell and gene therapy products, while Naomi Leach handles transactional IP matters, including licensing and collaboration agreements. Kristian Shearsby guides both start-ups and listed life sciences companies through corporate and IP transactions, with a strong nexus to the US market. Corporate specialist Michelle Gomes was promoted to partner in May 2024.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Alexandra Pygall has excellent industry knowledge and provides fantastic support for licensing and collaboration transactions. She is building a strong team of juniors and cross-functional specialists. She combines contentious and non-contentious experience to great effect.’
- 'Alexandra Pygall is a top-tier pharma and healthcare litigation partner. Laura Elliott is a rising star.'
Key clients
- Avacta Therapeutics
- Dr. Falk Pharma
Work highlights
Acted for Dr. Falk Pharma GmbH (a German family-owned, multi-national, pharmaceutical company business) on its successful acquisition of Kynos Therapeutics Ltd (a UK clinical-stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases).